在瘤学感染管理中的微生物组选择性DNA Pol IIIC抑制剂
Muhammad Shahid Mehmood1, Maryam Abid2, Naseeb Danaf3
1Faculty of Veterinary Science, Institute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
瘤学患者经常感染感染,抗生素可能会损害肠道微生物群. 新的DNA聚合酶IIIC抑制剂在治疗感染的同时保持肠道健康方面表现有前途,可能改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤学患者因化疗和免疫抑制而面临高感染率.
- 广谱抗生素破坏肠道微生物群,增加感染风险,降低免疫检查点抑制剂 (ICI) 疗效.
- 在ICI启动附近使用抗生素与生存率下降有关.
研究的目的:
- 评估DNA聚合酶IIIC抑制剂抗生素对瘤患者肠道微生物群的影响.
- 评估这些向抗生素在控制感染的有效性,同时保持微生物多样性.
- 探索微生物节约抗生素在支持抗癌疗法的潜力.
主要方法:
- 对瘤学中抗生素使用的临床数据和元分析的审查.
- 对研究DNA聚合酶IIIC抑制剂的研究进行分析,例如ibezapolstat.stat.
- 检查了关于这些向抗微生物药物的全类影响的会议数据.
主要成果:
- DNA聚合酶IIIC抑制剂在克洛斯特里迪奥伊德困难感染中显示出高临床治愈率 (88-96%).
- 这些抗生素保护了肠道微生物的多样性,并限制了抗菌素耐药性的出现.
- 新出现的数据表明,这些节约微生物群的效果可能适用于这些药物的整个类别.
结论:
- 向的DNA聚合酶IIIC抑制剂提供了一种策略来对抗免疫功能低下患者的感染.
- 使用这些药物来保护肠道微生物群的多样性可能会增强免疫功能和抗癌治疗反应.
- 这种方法有可能减少复发性感染并改善瘤治疗的结果.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
00:57Antibiotic Selection
59.3K
Overview
59.3K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
01:28Biological Methods for Microbial Control
776
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
776
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K